Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70470 | 0.89 | ALDH1A1 (0.65) | ALDH1A1MAPTKDM4ETDP1NPC1 | |
| SCHEMBL4657653 | 0.86 | MEN1 (0.56) | ALDH1A1TP53MAPTKDM4EGLA | |
| SCHEMBL1017792 | 0.86 | KDM4E (0.54) | ALDH1A1MAPTKDM4ENPC1RAB9A | |
| SCHEMBL10400378 | 0.83 | KDM4E (0.59) | ALDH1A1TP53MAPTKDM4ETDP1 | |
| SCHEMBL9080431 | 0.81 | KDM4E (0.62) | ALDH1A1TP53MAPTKDM4ETDP1 | |
| SCHEMBL3767347 | 0.81 | KDM4E (0.62) | ALDH1A1TP53MAPTKDM4ETDP1 | |
| SCHEMBL30967314 | 0.81 | KDM4E (0.62) | ALDH1A1TP53MAPTKDM4ETDP1 | |
| SCHEMBL17110515 | 0.81 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ENPC1RAB9A | |
| SCHEMBL3993408 | 0.81 | ALDH1A1 (0.49) | ALDH1A1TP53MAPTKDM4ETDP1 | |
| SCHEMBL5393044 | 0.81 | ALDH1A1 (0.64) | ALDH1A1TP53MAPTKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1919928-A | Polymer electrolyte material based on room temperature fused salt | BEIJING INST TECHNOLOGY (CN) | 2007-02-28 | — | — | CN | claimed |
| CN-1585185-A | Room-temperature molten salt electrolyte materials | NAT HIGH TECHNOLOGIES GREEN MA (CN) | 2005-02-23 | — | — | CN | claimed |
| CN-118580241-A | Tetrahydropyrrolo [3,4-c ] pyrazole compound, preparation method and application thereof in medicine | 江苏恒瑞医药股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-102613209-A | Group of 4-halogenated methyl-1, 2, 3-thiodiazole compounds and preparation method and application thereof | UNIV NANKAI | 2012-08-01 | — | — | CN | disclosed |
| CN-101891710-B | 4-halogenated methyl-1, 2, 3-thiadiazole compounds, and preparation method and application thereof | UNIV NANKAI | 2012-07-04 | — | — | CN | disclosed |
| US-7956070-B2 | Piperidines as chemokine modulators (CCR) | ASTRAZENECA AB (SE) | 2011-06-07 | — | — | US | disclosed |
| CN-101891710-A | 4-halogenated methyl-1, 2, 3-thiadiazole compounds, and preparation method and application thereof | UNIV NANKAI | 2010-11-24 | — | — | CN | disclosed |
| CN-101740813-A | Ionic liquid compound electrolyte material | BEIJING INST TECHNOLOGY | 2010-06-16 | — | — | CN | disclosed |
| CN-101740814-A | Ionic liquid electrolyte material | BEIJING INST TECHNOLOGY | 2010-06-16 | — | — | CN | disclosed |
| CN-100588685-C | Polymer electrolyte material based on room temperature fused salt | BEIJING INST TECHNOLOGY | 2010-02-10 | — | — | CN | disclosed |
| CN-101115715-A | Pyrrolidine derivatives for the treatment of diseases associated with renin activity | NOVARTIS AG (CH) | 2008-01-30 | — | — | CN | disclosed |
| CN-1314160-C | Room-temperature molten salt electrolyte materials | NAT HIGH TECHNOLOGIES GREEN MA (CN) | 2007-05-02 | — | — | CN | disclosed |
| CN-1938274-A | Novel piperidines as chemokine modulators (CCR) | ASTRAZENECA AB (SE) | 2007-03-28 | — | — | CN | disclosed |
| CN-1930120-A | Process for producing urethane (meth)acrylates and new urethane (meth)acrylates | CYTEC SURFACE SPECIALTIES SA (BE) | 2007-03-14 | — | — | CN | disclosed |
| US-20070054924-A1 | Novel piperidines as chemokine modulators (ccr) | ASTRAZENECA AB (SE) | 2007-03-08 | — | — | US | disclosed |
| CN-1919928-A | Polymer electrolyte material based on room temperature fused salt | BEIJING INST TECHNOLOGY (CN) | 2007-02-28 | — | — | CN | disclosed |
| EP-1713772-A1 | NOVEL PIPERIDINES AS CHEMOKINE MODULATORS (CCR) | AstraZeneca AB (SE) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005073192-A1 | NOVEL PIPERIDINES AS CHEMOKINE MODULATORS (CCR) | ASTRAZENECA AB (SE) | 2005-08-11 | — | — | WO | disclosed |
| CN-1585185-A | Room-temperature molten salt electrolyte materials | NAT HIGH TECHNOLOGIES GREEN MA (CN) | 2005-02-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054924-A1 | Novel piperidines as chemokine modulators (ccr) | CCR3, CCR1, CCR4 | ALDH1A1 994/4885TP53 4872/4885MAPT 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.